APLLTDAlembic Pharmaceuticals Ltd.

    Alembic Pharmaceuticals Ltd: results and news

    Every Alembic Pharmaceuticals Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · pharmaceuticals · Latest 4 Nov 2026

    A glass thermometer lying across a pile of white tablets, orange tablets and green-and-white capsules.

    APLLTDAlembic Pharmaceuticals Ltd.

    Alembic Pharmaceuticals Q2 FY27 Results: Consolidated Net Profit ₹334 Crore on Total Income of ₹2,619 Crore

    Alembic Pharmaceuticals (NSE: APLLTD) reported consolidated total income of ₹2,618.59 crore and net profit of ₹333.91 crore for the quarter ended 30 Sep 2026, it said in a filing on 04 Nov 2026. Standalone total income was ₹2,416.07 crore and standalone net profit ₹409.36 crore for the same quarter.

    • Earnings
    • pharmaceuticals

    Blacklitt Research3 min read